Literature DB >> 25511365

External validation of the Ottawa subarachnoid hemorrhage clinical decision rule in patients with acute headache.

M Fernanda Bellolio1, Erik P Hess2, Waqas I Gilani2, Tyler J VanDyck2, Stuart A Ostby2, Jessica A Schwarz2, Christine M Lohse2, Alejandro A Rabinstein2.   

Abstract

We aim to externally validate the Ottawa subarachnoid hemorrhage (OSAH) clinical decision rule. This rule identifies patients with acute nontraumatic headache who require further investigation. We conducted a medical record review of all patients presenting to the emergency department (ED) with headache from January 2011 to November 2013. Per the OSAH rule, patients with any of the following predictors require further investigation: age 40 years or older, neck pain, stiffness or limited flexion, loss of consciousness, onset during exertion, or thunderclap. The rule was applied following the OSAH rule criteria. Patients were followed up for repeat visits within 7 days of initial presentation. Data were electronically harvested from the electronic medical record and manually abstracted from individual patient charts using a standardized data abstraction form. Calibration between trained reviewers was performed periodically. A total of 5034 ED visits with acute headache were reviewed for eligibility. There were 1521 visits that met exclusion criteria, and 3059 had headache of gradual onset or time to maximal intensity greater than or equal to 1 hour. The rule was applied to 454 patients (9.0%). There were 9 cases of subarachnoid hemorrhage (SAH), yielding an incidence of 2.0% (95% confidence interval [CI], 1.0%-3.9%) in the eligible cohort. The sensitivity for SAH was 100% (95% CI, 62.9%-100%); specificity, 7.6% (95% CI, 5.4%-10.6%); positive predictive value, 2.1% (95% CI 1.0%-4.2%); and negative predictive value, 100% (95% CI, 87.4%-100%). The OSAH rule was 100% sensitive for SAH in the eligible cohort. However, its low specificity and applicability to only a minority of ED patients with headache (9%) reduce its potential impact on practice.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25511365     DOI: 10.1016/j.ajem.2014.11.049

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

1.  Validation of the Ottawa Subarachnoid Hemorrhage Rule in patients with acute headache.

Authors:  Jeffrey J Perry; Marco L A Sivilotti; Jane Sutherland; Corinne M Hohl; Marcel Émond; Lisa A Calder; Christian Vaillancourt; Venkatesh Thirganasambandamoorthy; Howard Lesiuk; George A Wells; Ian G Stiell
Journal:  CMAJ       Date:  2017-11-13       Impact factor: 8.262

2.  To Head CT Scan or Not: The Clinical Quandary in Suspected Subarachnoid Hemorrhage; a Validation Study on Ottawa Subarachnoid Hemorrhage Rule.

Authors:  Abdul-Sajjad Pathan; Eleonora Chakarova; Aamir Tarique
Journal:  Adv J Emerg Med       Date:  2018-04-01

3.  Subarachnoid haemorrhage rules in the decision for acute CT of the head: external validation in a UK cohort.

Authors:  Robert W Foley; Sanjeev Ramachandran; Abisoye Akintimehin; Samuel Williams; Steve J Connor; Jonathan Hart; Yasmin K Kapadia; Ivan Timofeev; Christos M Tolias; Martin B Whyte; Philip A Kelly
Journal:  Clin Med (Lond)       Date:  2021-03       Impact factor: 2.659

Review 4.  Subarachnoid hemorrhage in the emergency department.

Authors:  Sima Patel; Amay Parikh; Okorie Nduka Okorie
Journal:  Int J Emerg Med       Date:  2021-05-12

Review 5.  Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage.

Authors:  Won-Sang Cho; Jeong Eun Kim; Sukh Que Park; Jun Kyeung Ko; Dae-Won Kim; Jung Cheol Park; Je Young Yeon; Seung Young Chung; Joonho Chung; Sung-Pil Joo; Gyojun Hwang; Deog Young Kim; Won Hyuk Chang; Kyu-Sun Choi; Sung Ho Lee; Seung Hun Sheen; Hyun-Seung Kang; Byung Moon Kim; Hee-Joon Bae; Chang Wan Oh; Hyeon Seon Park
Journal:  J Korean Neurosurg Soc       Date:  2018-02-28

6.  Patient with a Subarachnoid Headache.

Authors:  Ethan T Montemayor; Brit Long; James A Pfaff; Gregory P Moore
Journal:  Clin Pract Cases Emerg Med       Date:  2018-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.